Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVO crawled time : 08:00 save search
Novo Nordisk A/S - Articles of Association 2024
Published: 2024-03-25 (Crawled : 08:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.19%
H: 0.97%
C: 0.04%
association
Novo Holdings Portfolio Company Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
Published: 2024-03-14 (Crawled : 08:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.77%
H: 0.05%
C: -0.93%
pharma company astrazeneca acquired agreement
Novo Holdings invests in Manipal Hospitals, a leading private hospital chain in India
Published: 2024-02-06 (Crawled : 08:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: -0.61%
hospital india
Novo Nordisk A/S - share repurchase programme
Published: 2024-02-06 (Crawled : 08:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: -0.61%
repurchase
2023 Novo Holdings Seed Investments Team Annual Review/Business Update
Published: 2024-01-04 (Crawled : 08:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.44%
H: 3.68%
C: 2.4%
investments update
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published: 2023-12-19 (Crawled : 08:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.91%
H: 0.72%
C: 0.11%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 13.88%
H: 0.0%
C: -3.58%
pharma natural cell sanofi
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: -2.79%
H: 0.62%
C: 0.62%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.06%
H: 0.82%
C: 0.82%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -2.2%
H: 0.0%
C: -0.27%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -0.64%
H: 0.5%
C: 0.5%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.42%
H: 0.67%
C: 0.25%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.2%
H: 0.55%
C: 0.1%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.08%
H: 1.45%
C: 1.17%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.05%
H: 0.3%
C: -0.76%
reach market
Orexo announces changes in the company´s Board of Directors - October 27, 2023
Published: 2023-10-27 (Crawled : 08:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.5%
H: 0.78%
C: -0.29%
Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) receives CHMP positive opinion for expanded use in children and adolescents with growth hormone deficiency
Published: 2023-05-26 (Crawled : 08:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.74%
H: 0.64%
C: -0.41%
sogroya chmp children positive growth hormone
Zealand Pharma Announces Full Year Results for 2022
Published: 2023-03-02 (Crawled : 08:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.53%
H: 1.28%
C: 1.06%
pharma year
Innate Pharma to present adenosine franchise, IPH5201 and IPH5301 at ESMO IO 2022
Published: 2022-12-01 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 5.99%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.64%
H: 2.88%
C: 2.88%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.25%
H: 0.2%
C: -0.02%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.96%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 4.56%
H: 1.86%
C: 1.86%
iph5201 pharma
Innate Pharma to Present Lacutamab PTCL Phase 1b Design and ANKET™ Platform at ESMO 2022
Published: 2022-09-05 (Crawled : 08:00) - biospace.com/
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
| Email alert
Add to watchlist
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
IPHYF | $2.65 104.6% 300
|
Health Technology
| Email alert
Add to watchlist
pharma platform phase 2b
Novo Holdings leads $50 million investment in MedGenome to accelerate expansion into new markets and deepen product offerings
Published: 2022-08-30 (Crawled : 08:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.17%
H: 0.23%
C: -1.14%
expansion
Innate Pharma Announces IPH5201 Phase 2 Study in Lung Cancer
Published: 2022-06-03 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 1.65%
H: 0.0%
C: -0.32%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.65%
H: 0.63%
C: 0.16%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.09%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 2.96%
H: 0.98%
C: -1.15%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.56%
H: 0.82%
C: -0.64%
iph5201 pharma cancer phase 2
Novo Nordisk achieves primary objectives of ONWARDS 1 and 6 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin glargine U100 in ONWARDS 1
Published: 2022-06-03 (Crawled : 08:00) - globenewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.65%
H: 0.63%
C: 0.16%
trials glargine insulin
Novo Holdings Portfolio Company F2G enters strategic collaboration with Shionogi to commercialise its new antifungal agent Olorofim in Europe and Asia
Published: 2022-05-16 (Crawled : 08:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -2.14%
H: 1.02%
C: 0.02%
europe collaboration
Engimmune Therapeutics raises CHF 15.5 million in seed financing to develop novel T-cell receptor therapeutics
Published: 2022-05-03 (Crawled : 08:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.59%
H: 0.96%
C: -0.04%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.01%
H: 0.0%
C: 0.0%
t-cell therapeutics
Innate Pharma Announces Conference Call and Webcast for Q1 2022 Business Update
Published: 2022-05-03 (Crawled : 08:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.59%
H: 0.96%
C: -0.04%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 1.4%
H: 1.38%
C: -0.35%
pharma conference
Innate Pharma Reports Full Year 2021 Financial Results and Business Update
Published: 2022-03-24 (Crawled : 08:00) - biospace.com/
BNPQY | $34.61 -2.68% 100K
|
Finance and Insurance
|
| O: -0.98%
H: 1.17%
C: 0.78%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -1.27%
H: 0.98%
C: 0.93%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -3.17%
results pharma
Innate Pharma to Participate in Upcoming Investor Conferences - Feb 04, 2022
Published: 2022-02-04 (Crawled : 08:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -2.42%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -2.48%
H: 0.0%
C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K
|
Health Technology
|
| O: -4.02%
H: 0.52%
C: 0.0%
conference pharma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.